51 – 60 of 256
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Register data support the long-term safety of the use of ultra-hypofractionated radiotherapy for localised prostate cancer previously seen in the phase 3 trial HYPO-RT-PC : ESTRO 2024 congress report
2024)(
- Other contribution › Web publication
-
Mark
BioMEL : a translational research biobank of melanocytic lesions and melanoma
(
- Contribution to journal › Article
-
Mark
Cost of Illness of Head and Neck Cancer in Sweden
(
- Contribution to journal › Article
-
Mark
Beyond Average : a-Particle Distribution and Dose Heterogeneity in Bone Metastatic Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Minimal invasive LASER-resection vs. radiotherapy as primary treatment of early glottic cancer. A population-based study with, up to 16 years follow up of survival, rate of laryngectomy and voice function
(
- Contribution to journal › Article
- 2023
-
Mark
Decreasing the Adverse Effects in Pelvic Radiation Therapy : A Randomized Controlled Trial Evaluating the Use of Probiotics
(
- Contribution to journal › Article
-
Mark
Predictors of survival in advanced oral cancers after salvage surgery with free tissue flap reconstruction
(
- Contribution to journal › Article
-
Mark
Imaging ovarian cancer - from baseline characteristics to high-risk image factors
(
- Contribution to journal › Article
-
Mark
A Novel Anthropomorphic Phantom Composed of Tissue-Equivalent Materials for Use in Experimental Radiotherapy : Design, Dosimetry and Biological Pilot Study
(
- Contribution to journal › Article
-
Mark
Exploring Spatial Heterogeneity of Immune Cells in Nasopharyngeal Cancer
(
- Contribution to journal › Article